Related Experiment Videos
Identifying the osteopenic patient and preventing worsening of the disease
1School of Medicine, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA. dermanr@umkc.edu
Abstract:
Osteopenia is a progressive condition that places patients at risk for increased morbidity and mortality if untreated. Patients with bone loss of at least 1.0 standard deviation (SD) from normal are considered osteopenic, whereas those with bone loss of at least 2.5 SDs are considered osteoporotic. Osteoporotic patients are treated to stop bone loss and restore bone mineral density. Patients with bone loss in the osteopenic range, even osteopenic patients with additional risk factors, might not receive treatment. National Osteoporosis Foundation guidelines recommend treatment when bone loss is 2.0 SDs, or less when additional risk factors are present. This is supported by the literature; treatments for bone loss are approved for the prevention of osteoporosis.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
What is the Skeletal System?
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...